expands on this, saying, “We know conditions like liver cancer or hepatoma are very common in this region. But, we’ve been conducting novel combination immunotherapies related to aggressive cancers like liver cancer, breast cancer, and lung cancer.Those are things we do quite well.” Of course, maintaining the highest standards of quality during research and development is paramount, so the center’s National Cancer Institute designation serves as a rigorous benchmark of accountability. As one of only 73 such centers in the nation, the University of Hawai’i Cancer Center ranks in the top 4% of cancer centers nationwide. It must regularly secure a Cancer Center Support Grant (CCSG), a demanding process that involves a comprehensive review of its overall strategy, program progress, publications, and impact. This includes detailed strategic write-ups for each program, clearly defined key performance indicators, received when delivered by trusted, relatable figures within the community itself. By doing so, the center creates a buy-in effect from within the community. ENSURING HIGH QUALITY WITHIN ADVANCED RESEARCH Thanks to its cultural considerations, the University of Hawai‘i Cancer Center stands at the forefront of significant research and development. A key area of focus is leveraging its large, world renowned Multiethnic Cohort clinical database and sample repository to understand disease incidence in of various racial and ethnic groups. Launched in 1993 he MEC Study is the most ethnically diverse epidemiologic study in the world that investigates the roles of lifestyle, diet and genetics in cancer and other chronic diseases. This unique resource has produced numerous landmark scientific findings. It also has enabled the adjustment and adaptation of screening guidelines to better suit the diverse population. Dr. Ueno 5 BUSINESS VIEW MAGAZINE VOLUME 12, ISSUE 07 THE UNIVERSITY OF HAWAI‘I CANCER CENTER
RkJQdWJsaXNoZXIy MTI5MjAx